Huron Consulting Group (HURN) to Release Earnings on Tuesday

Huron Consulting Group (NASDAQ:HURN) will be posting its quarterly earnings results after the market closes on Tuesday, April 30th. Analysts expect Huron Consulting Group to post earnings of $0.88 per share for the quarter. Huron Consulting Group has set its FY24 guidance at $5.35-5.95 EPS and its FY 2024 guidance at 5.350-5.950 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Huron Consulting Group (NASDAQ:HURN) last announced its earnings results on Tuesday, February 27th. The business services provider reported $1.29 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.17. The company had revenue of $339.23 million during the quarter, compared to the consensus estimate of $341.71 million. Huron Consulting Group had a net margin of 4.47% and a return on equity of 17.77%. Huron Consulting Group’s revenue was up 8.1% compared to the same quarter last year. During the same period last year, the firm earned $1.12 earnings per share. On average, analysts expect Huron Consulting Group to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Huron Consulting Group Price Performance

Shares of HURN opened at $93.63 on Friday. The company has a market cap of $1.73 billion, a price-to-earnings ratio of 29.26 and a beta of 0.58. Huron Consulting Group has a twelve month low of $70.66 and a twelve month high of $113.31. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.61. The company has a 50 day moving average of $96.67 and a two-hundred day moving average of $100.80.

Insider Transactions at Huron Consulting Group

In other news, Director James H. Roth sold 9,517 shares of Huron Consulting Group stock in a transaction on Monday, March 4th. The shares were sold at an average price of $99.28, for a total transaction of $944,847.76. Following the completion of the sale, the director now directly owns 83,239 shares in the company, valued at $8,263,967.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director James H. Roth sold 2,000 shares of the firm’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $103.22, for a total transaction of $206,440.00. Following the completion of the transaction, the director now owns 68,040 shares of the company’s stock, valued at $7,023,088.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director James H. Roth sold 9,517 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $99.28, for a total transaction of $944,847.76. Following the transaction, the director now directly owns 83,239 shares of the company’s stock, valued at approximately $8,263,967.92. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,080 shares of company stock worth $4,146,076. Company insiders own 2.02% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. StockNews.com downgraded shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 28th. Barrington Research lifted their price objective on shares of Huron Consulting Group from $128.00 to $133.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.